Chemkart India IPO is a fully book-built issue, offering a total of 32.30 lakh shares. The share offering comprises a fresh issue of 26 lakh shares and an offer-for-sale of 6.3 lakh shares.
The IPO opens on July 7, 2025 and closes on July 9, 2025. The allotment process is expected to be finalized by July 10, 2025. The Chemkart India IPO is scheduled to list on BSE SME, with a tentative listing date of July 14, 2025.
The price band for the Chemkart India IPO is ₹236 to ₹248 per share.
Registrar for this IPO is Bigshare Services Private Limited and lead managers for Chemkart India IPO are Smart Horizon Capital Advisors Private Limited.
Explore more upcoming IPOs in India for comparison and investment planning.
IPO Schedule
| IPO Open Date | Monday, 07 Jul, 2025 |
|---|---|
| IPO Close Date | Wednesday, 09 Jul, 2025 |
| IPO Allotment Date | Thursday, 10 Jul, 2025 |
| Refund Initiation | Friday, 11 Jul, 2025 |
| Share credit in Demat | Friday, 11 Jul, 2025 |
| Listing Date | Monday, 14 Jul, 2025 |
Key Details
| Price Band | ₹236 to ₹248 Per Share |
|---|---|
| Lot Size | 600 Shares |
| Face Value | ₹10 Per Equity Share |
| Total Issue Size | 3,063,000 Shares |
| Fresh Issue | 2,433,800 Shares |
| OFS Issue | 629,200 Shares |
| Issue Type | Fresh Offer & Offer for Sale |
| Listing At | BSE SME |
Share Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB | 50% |
| Retail | 35% |
| NII/HNI | 15% |
Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 600 | 148,800 |
| Retail (Max) | 1 | 600 | 148,800 |
| S-HNI (Min) | 2 | 1200 | 297,600 |
| S-HNI (Max) | 6 | 3600 | 892,800 |
About Chemkart India Limited Company
Chemkart India Limited is a one-stop destination for nutritional, health, and sports supplement products, with a focus on food products offering health benefits alongside nutritional value. Based in Mumbai, the company offers a diverse range of products across seven categories: Amino Acids, Health Supplements, Herbal Extracts, Nucleotides, Proteins, Sports Nutrition, and Vitamins.
For the Financial Year 2024, Chemkart's revenue from operations was ₹132.03 million, up from ₹131.38 million in FY23 and ₹86.98 million in FY22, demonstrating a CAGR of 23.20% between FY22 and FY24. Revenue from operations for the period ended September 30, 2024, was ₹113.13 million.
Chemkart targets the Business-to-Business (B-to-B) platform, providing ingredients for manufacturing finished supplements. Their customer-centric approach aims to fulfill daily and aspirational needs with a focus on variety, affordability, quality, and convenience. Chemkart maintains strong relationships with both customers and suppliers, enhancing supply chain processes. The company operates from its registered office in Mumbai and a warehousing facility in Bhiwandi, Thane, covering approximately 28,259 sq. ft., which includes blending and grinding equipment.
Chemkart India Limited Financial Details
| Category | March 2024 | March 2023 | March 2022 |
|---|---|---|---|
| Total Assets | ₹53.51 | ₹37.48 | ₹24.54 |
| Total Revenue/Total Income | ₹132.83 | ₹131.69 | ₹87.43 |
| Profit After Tax | ₹14.52 | ₹7.66 | ₹5.48 |
| Net Worth | ₹29.01 | ₹14.50 | ₹6.84 |
| Total Borrowings | ₹21.97 | ₹28.74 | ₹37.50 |
₹ In Crore
Key Performance Indicator
| Basic EPS (in ₹) | Return on Net Worth (RoNW) | Net Asset Value (NAV) | Debt-Equity Ratio | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
|---|---|---|---|---|---|
| 15.28 | 50.04% | 30.55 |
Offer Objectives
The offer objects consist of equity shares held by promoters and other shareholders. Mr. Ankit Shailesh Mehta and Ms. Parul Shailesh Mehta each held 47,49,465 shares, representing 50% of the pre-offer equity share capital. Mr. Shailesh Vinodrai Mehta held a negligible amount of shares.
Key transactions include bonus issues on December 27, 2024, where Mr. Ankit Shailesh Mehta and Ms. Parul Shailesh Mehta each received 40,70,970 and 40,71,000 shares respectively. The promoters’ contribution is locked in, with up to 26,00,000 shares locked in for three years to meet the minimum 20% post-offer requirement.
Shares exceeding the minimum promoters’ contribution are subject to lock-in as per SEBI ICDR regulations, with 50% locked in for two years and the remaining 50% for one year. The entire pre-issue capital held by non-promoters is locked in for one year. A portion of equity shares allotted to Anchor Investors under the Anchor Investor Portion shall be locked -in for a period of 90 days from the date of Allotment and the remaining Equity Shares allotted to Anchor Investors under the Anchor Investor Portion shall be locked -in for a period of 30 days from the date of Allotment.
The company confirms compliance with SEBI ICDR regulations regarding lock-in, pledge, and transferability of equity shares. No buyback arrangements exist, and all offered equity shares will be fully paid-up.
Company Details
Address:
Office No. 403/404, 4th Floor, K.L. Accolade,
6th Road, TPS III, Santacruz (East),
Mumbai - 400055, Maharashtra, India
Phone: +91 9136383828
Email: [email protected]
Website: https://chemkart.com/
IPO Registrar Details
Bigshare Services Private Limited
Phone: 022 - 6263 8200
Email: [email protected]
Website: http://www.bigshareonline.com
Offer Prospectus & Documents
Lead Managers
- Smart Horizon Capital Advisors Private Limited
